cholesterol
Showing 1 - 25 of >10,000
Cholesterol Levels Trial in Alexandroupolis (Lacticaseibacillus with oats, Plain oats)
Active, not recruiting
- Cholesterol Levels
- Lacticaseibacillus with oats
- Plain oats
-
Alexandroupolis, East Macedonia And Thrace, GreeceDemocritus University of Thrace
Oct 25, 2023
Hypercholesterolemia, Dyslipidemias Trial in Hamburg (lipodia)
Not yet recruiting
- Hypercholesterolemia
- Dyslipidemias
- lipodia
-
Hamburg, GermanyGAIA AG
Aug 3, 2023
Hypercholesterolemia Trial in Edmonton (Kefir)
Completed
- Hypercholesterolemia
- Kefir
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jan 11, 2023
Acute Metabolic Effects of Evolocumab and Atorvastatin Trial (Evolocumab)
Not yet recruiting
- Acute Metabolic Effects of Evolocumab and Atorvastatin
- (no location specified)
Nov 16, 2023
Inborn Errors of Cholesterol Synthesis and Related Disorders
Recruiting
- Lysosomal Storage Disease
- Cholesterol Metabolism
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022
Hypercholesterolemia Trial
Not yet recruiting
- Hypercholesterolemia
- (no location specified)
Dec 23, 2022
Diet, Habits Trial (Chia Seeds and instant oatmeal breakfast, Cheerio Breakfast, Instant Oatmeal breakfast)
Completed
- Diet
- Habits
- Chia Seeds and instant oatmeal breakfast
- +2 more
- (no location specified)
Feb 15, 2023
Cholesterol, HDL, Lipid Metabolism, Inborn Errors, Tangier Disease Trial in Philadelphia (3H-cholesterol bound to albumin)
Suspended
- Cholesterol, HDL
- +4 more
- 3H-cholesterol bound to albumin
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 14, 2022
Different Equations to Accurately Calculate LDL Cholesterol
Active, not recruiting
- Dyslipidemias
- Lipid Disorder
- no intervention, Serum LDL cholesterol calculation
-
Bron, FranceLaboratoire de Biologie Médicale Multi Sites, Centre de Biologie
Oct 24, 2022
Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
- Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
- (no location specified)
Mar 14, 2023
Hyperlipidemias, Hypercholesterolemia Trial in Chios (Chios Mastiha essential oil, Placebo)
Completed
- Hyperlipidemias
- Hypercholesterolemia
- Chios Mastiha essential oil
- Placebo
-
Chios, GreeceSkylitseio General Hospital
May 11, 2023
Elevated Low-Density Lipoprotein Cholesterol Trial in Herston, Adelaide, Melbourne (SNK-396 - SAD cohort, SNK-396 - MAD Cohort)
Recruiting
- Elevated Low-Density Lipoprotein Cholesterol
- SNK-396 - SAD cohort
- SNK-396 - MAD Cohort
-
Herston, Queensland, Australia
- +2 more
Jun 6, 2023
Hypercholesterolemia, Insulin Resistance, Insulin Secretion Trial in Tuebingen (Lowering cholesterol concentrations by PCSK-9
Recruiting
- Hypercholesterolemia
- +2 more
- Lowering cholesterol concentrations by PCSK-9 inhibitor
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Aug 24, 2022
The Genetic, Protein, and Lipid Basis of Variation in
Active, not recruiting
- Lipid Metabolism Disorders
-
Dallas, TexasUT Southwestern Medical Center
Dec 21, 2022
To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other
Not yet recruiting
- To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
- Combination for Subgroup High LDL-c Patients With Other Comorbidities
- RN0191 INJECTION
- (no location specified)
Jun 14, 2023
Study of Smith-Lemli-Opitz Syndrome
Completed
- Smith-Lemli-Opitz Syndrome
- Cholesterol Suspension
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (Dexamethasone (Group 2), Cosyntropin (Group 3), PET/CT Scan with
Recruiting
- Radiotracer
- +2 more
- Dexamethasone (Group 2)
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan
Dec 9, 2022
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Cholesterol metabolism disruption
-
Quebec city, Quebec, CanadaCHU de Québec-Université Laval
Oct 17, 2022
Cardiovascular Health Trial in Alhendín (Garlic and onion concentrate, Control)
Recruiting
- Cardiovascular Health
- Garlic and onion concentrate
- Control
-
Alhendín, Granada, SpainDomca Sau
May 20, 2022
LDL-cholesterol Trial in Jena (statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran)
Recruiting
- LDL-cholesterol
- statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
-
Jena, Thuringia, GermanyUniversity Hospital Jena
Oct 17, 2022
Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)
Not yet recruiting
- Primary Hypercholesterolemia or Mixed Dyslipidemia
- Inclisiran
- Matching Placebo for Inclisiran
- (no location specified)
May 24, 2023
Cardiovascular Disease Trial in Seoul (Intensive targeting group, Conventional therapy group)
Recruiting
- Cardiovascular Disease
- Intensive targeting group
- Conventional therapy group
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Oct 7, 2022
Human Thyroid and Iodine Resistance
Recruiting
- Thyroid Cancer
- Metabolites dosage
-
Toulouse, FranceInstitut Claudius regaud IUCT Oncopole
Dec 22, 2022
Hypercholesterolemia, Hyperlipidemias, Physical Inactivity Trial in Adelaide (Egg diet, Egg-free Diet, Control Diet)
Recruiting
- Hypercholesterolemia
- +3 more
- Egg diet
- +2 more
-
Adelaide, South Australia, AustraliaUniversity of South Australia Clinical Trial Facility
Mar 1, 2022